1 Matching Annotations
  1. Oct 2020
    1. In Cantrell's view, pharmaceutical companies are the only ones that have the money to do long-term studies on drug's efficacy, "but there's absolutely no financial incentive for them to do it." (When the medicine you need expires, you, or your insurer, pay for more.)